Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in a Korean Population: A 52-Week Prospective Study-Reference-Cited by-同舟云学术

Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in a Korean Population: A 52-Week Prospective Study

Published:2008 Issue:1 Volume:23 Page:10
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:
Short-container-title:J Korean Med Sci

Author:

Suh Guk-Hee¹,Jung Hee Yeon²,Lee Chang Uk³,Choi Sungku⁴,

Affiliation:

1. Department of Psychiatry, Hallym University College of Medicine, Seoul, Korea.

2. Department of Psychiatry, Boramae Hospital, Seoul National University, College of Medicine, Seoul, Korea.

3. Department of Psychiatry, the Catholic University of Korea College of Medicine, Seoul, Korea.

4. Janssen Korea Pharmaceutical, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2008.23.1.10

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of herbal medicine (Jujadokseo-hwan) on quality of life in patients with mild cognitive impairment: Cost-effectiveness analysis alongside randomized controlled trial;Integrative Medicine Research;2023-03

2. Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis;Cost Effectiveness and Resource Allocation;2022-04-20

3. Effectiveness and safety of acupuncture in treating sleep disturbance in dementia patients;Medicine;2021-08-13

4. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia;Cochrane Database of Systematic Reviews;2021-02-03

5. A systematic review of interventions that reduce family caregiving time;Bridging the Family Care Gap;2021